Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity now available at the Rutherford Cancer Centre North West in Liverpool.
Professor Andrew Drakeley is a Consultant Gynaecologist at Rutherford Cancer Centre North West. He has practised at the Liverpool Women’s NHS Foundation Trust since 2005. He's also been the Clinical Director of the Hewitt Fertility Centre since 2016, Gynaecology Clinical Director since 2018, Deputy Medical Director since 2021 and Cheshire & Mersey Gynaecology Clinical Lead since 2021.
Professor Andrew Drakeleyis currently the RCOG Vice Chair for subspecialty training and Clinical Program Lead for two master’s level courses at Edge Hill University: MSc advanced fertility practice and MCh (O&G).
Professor Andrew Drakeley's special interests include: Reproductive medicine; IVF; surgical sperm retrieval; recurrent miscarriage; andrology; female infertility; male infertility; egg donation; egg sharing; surrogacy; viral discordancy; fertility preservation; menopause; pelvic pain; laparoscopy; fibroids; myomectomy; ambulatory hysteroscopy; endometrial polyps; ovarian cysts; heavy periods.
British Fertility Society
Honorary Supervisor, University of Liverpool
Consultant Gynaecologist & Subspecialist in Reproductive Medicine, Liverpool Women’s NHS Foundation Trust
Honorary Senior Clinical Lecturer, Edge Hill University
Honorary Visiting Professor, Guadalajara University, Mx
Assisted conception, sperm DNA fragmentation, ovulation induction, OHSS, artificial intelligence to select sperm and embryos.
Nancarrow L., Tempest N, Drakeley A.J, Homburg R, Russell R, Hapangama DK. National Survey Highlights the Urgent Need for Standardisation of Embryo Transfer Techniques in the UK. J. Clin. Med. 2021, 10, 2839. https://doi.org/ 10.3390/jcm10132839
Siristatidis, C., Stavros, S., Drakeley, A., Bettocchi, S., Pouliakis, A., Drakakis, P., Papapanou, M., & Vlahos, N. (2021). Omics and Artificial Intelligence to Improve In Vitro Fertilization (IVF) Success: A Proposed Protocol. Diagnostics (Basel, Switzerland), 11(5), 743. https://doi.org/10.3390/diagnostics11050743
Tempest N, Batchelor E, Hill CJ, Al-Lamee H, Drury J, Drakeley AJ, Hapangama D. Anterior gradient protein 3 and S100 calcium-binding protein P levels in different endometrial epithelial compartments may play an important role in recurrent pregnancy failure. Int. J. Mol. Sci. 2021, 22(8), 3835; https://doi.org/10.3390/ijms22083835
Chatters R, et al., A randomised controlled trial to assess the clinical effectiveness and safety of the endometrial scratch procedure prior to first-time
Professor Andrew Drakely does not hold a share or financial interest in the Rutherford Cancer Centres or another Rutherford Health plc company.
Professor Andrew Drakely does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Rutherford Health plc company.
Professor Andrew Drakely does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Rutherford Health plc.
Get in Touch
If you'd like to speak to us about any of the treatments we offer please don’t hesitate to get in touch. Call us on 0800 210 0402 or